This guidance summarises current NHS and GOV.UK advice for general practice teams supporting patients travelling overseas.
Community Pharmacies work, the funding streams and contracting arrangements and the requirements for being a community pharmacist
Educational podcasts and videos focusing on Consultations.
Don’t forget to log your learning points & reflections as part of your CPD. CQC are particularly keen to see any evidence of your learning and how you apply it
Injectable weight loss drugs have been brought to the UK market in the last few years including Semaglutide (Wegovy) launched in the UK on 4 September 2024 and Tirzepatide (Mounjaro) joining it a few months later.
The BMA offer guidance on cannabis-based medicinal products which details what constitutes a cannabis-based product for medicinal use, who can prescribe them, and under what circumstances.
Electronic Prescribing Service – Phase 4 was deployed from 18th November 2019, initially to TPP SystmOne following a pilot in 2018, and then to EMIS. It was enabled for the Vision and Microtest GP clinical systems in 2023.
‘Prescription direction’ occurs where a patient is being directed by their GP practice to a certain pharmacy to have their prescription dispensed.